Monoclonal antibodies crucial to fighting emerging infectious diseases, say NIAID officials

(NIH/National Institute of Allergy and Infectious Diseases) Monoclonal antibodies (mAbs) -- preparations of a type of antibody designed to bind to a single target -- have shown promise in the fight against cancer and autoimmune diseases. They also may play a role in future battles against emerging infectious disease outbreaks, according to an NEJM article by NIAID scientists. The article outlines the potential uses for mAbs as treatments for infectious diseases, as prevention for protecting at-risk individuals, and slowing disease outbreaks
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news